Sebastiano Andò Selected Research

Sebastiano Andò Research Topics

Disease

116	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2002
104	Neoplasms (Cancer) 10/2023 - 07/2002
26	Obesity 06/2023 - 03/2009
20	Carcinogenesis 05/2023 - 05/2004
13	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2006
6	Inflammation (Inflammations) 05/2023 - 01/2020
5	Triple Negative Breast Neoplasms 01/2023 - 04/2015
5	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 06/2004
4	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2020
4	Seminoma 01/2019 - 12/2005
4	Leydig Cell Tumor 05/2012 - 08/2007
3	Body Weight (Weight, Body) 01/2021 - 08/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 12/2016
3	Insulin Resistance 03/2020 - 08/2011
3	Thyroid Neoplasms (Thyroid Cancer) 01/2014 - 10/2006
3	Endometrial Neoplasms (Endometrial Cancer) 07/2012 - 03/2006
2	Goiter 10/2023 - 10/2019
2	Carcinoma (Carcinomatosis) 01/2023 - 07/2019
2	Disease Progression 03/2021 - 01/2016
2	Pathologic Processes 01/2021 - 01/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

44	Estrogens (Estrogen)FDA Link 09/2021 - 07/2002
28	Estrogen ReceptorsIBA 08/2023 - 07/2002
27	Hormones (Hormone)IBA 05/2023 - 07/2002
27	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2004
26	Estrogen Receptor alphaIBA 01/2021 - 07/2002
23	LeptinIBA 01/2023 - 08/2003
23	LigandsIBA 01/2023 - 09/2005
21	Aromatase (CYP19)IBA 09/2021 - 07/2002
16	AdipokinesIBA 05/2023 - 11/2011
14	AndrogensIBA 08/2023 - 07/2002
13	Tamoxifen FDA LinkGeneric 01/2021 - 03/2006
12	Androgen Receptors (Androgen Receptor)IBA 08/2023 - 05/2005
12	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 07/2002
10	AdiponectinIBA 05/2023 - 01/2014
10	Messenger RNA (mRNA)IBA 09/2021 - 09/2007
10	ElementsIBA 07/2021 - 02/2007
10	CytokinesIBA 07/2021 - 04/2007
9	Cyclin D1IBA 11/2019 - 03/2009
8	Aromatase InhibitorsIBA 01/2022 - 07/2002
8	Antineoplastic Agents (Antineoplastics)IBA 09/2020 - 05/2013
8	EnzymesIBA 11/2019 - 07/2002
8	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016 - 06/2004
8	Insulin-Like Growth Factor I (IGF-1)IBA 01/2015 - 09/2007
7	Conditioned Culture MediaIBA 06/2023 - 01/2016
7	Leptin ReceptorsIBA 01/2021 - 11/2011
7	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2021 - 05/2010
7	PPAR gammaIBA 10/2020 - 09/2005
6	ResveratrolIBA 06/2023 - 07/2009
6	Insulin (Novolin)FDA Link 01/2023 - 06/2007
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020 - 09/2005
6	Estrogen Receptor betaIBA 02/2014 - 06/2004
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2012
5	Insulin-Like PeptidesIBA 01/2019 - 07/2006
5	SteroidsIBA 01/2016 - 06/2004
4	MicroRNAs (MicroRNA)IBA 10/2023 - 03/2016
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2020 - 11/2013
4	Therapeutic UsesIBA 09/2020 - 10/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 05/2009
4	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2019 - 01/2016
4	Tyrosine (L-Tyrosine)FDA Link 01/2014 - 10/2009
4	Epidermal Growth Factor (EGF)IBA 05/2010 - 08/2008
3	Docosahexaenoic AcidsIBA 01/2023 - 06/2013
3	Dehydroepiandrosterone (DHEA)IBA 01/2023 - 07/2002
3	Cadherins (E-Cadherin)IBA 01/2023 - 04/2007
3	Small Interfering RNA (siRNA)IBA 01/2023 - 04/2011
3	Phosphotransferases (Kinase)IBA 08/2022 - 06/2009
3	AntioxidantsIBA 07/2021 - 01/2016
3	RetinoidsIBA 07/2021 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 09/2020 - 09/2007
3	ChromatinIBA 11/2019 - 04/2007
3	progesterone receptor BIBA 08/2019 - 11/2014
3	Protein Isoforms (Isoforms)IBA 01/2019 - 06/2009
3	GW 4064IBA 02/2016 - 02/2010
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2016 - 05/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2013
3	afimoxifene (hydroxytamoxifen)IBA 05/2010 - 03/2006
3	Cyclic AMP (AMP, Cyclic)IBA 03/2009 - 04/2007
3	ErbB Receptors (EGF Receptor)IBA 03/2009 - 02/2007
3	Carrier Proteins (Binding Protein)IBA 03/2009 - 04/2007
2	IodineIBA 10/2023 - 10/2019
2	Ethanolamine (Colamine)IBA 01/2023 - 06/2013
2	Oxygen (Dioxygen)IBA 01/2023 - 03/2011
2	ChemokinesIBA 01/2023 - 11/2019
2	Lysine (L-Lysine)FDA Link 08/2022 - 06/2009
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022 - 01/2019
2	PolyphenolsIBA 07/2021 - 06/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2021 - 06/2013
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 06/2004
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2019 - 01/2016
2	Steroid Receptors (Steroid Receptor)IBA 11/2019 - 06/2004
2	Dopamine (Intropin)FDA LinkGeneric 09/2019 - 11/2015
2	Phenobarbital (Luminal)FDA Link 08/2019 - 10/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2019 - 09/2016
2	Peptides (Polypeptides)IBA 07/2019 - 05/2015
2	Fas Ligand Protein (Fas Ligand)IBA 11/2017 - 02/2009

Therapy/Procedure

35	Therapeutics 01/2023 - 06/2009
3	Precision Medicine 10/2023 - 07/2019
2	Mediterranean Diet 10/2023 - 07/2021
2	Radiotherapy 01/2023 - 02/2010